Functional diversity of microglia - How heterogeneous are they to begin with?

Frontiers in Cellular Neuroscience

Volumn 7, Issue MAY, 2013, Pages

  Hanisch, Uwe Karsten ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Cytokines; Diversity; Experience; Immunity; Innate; Microglia; Subtypes; TLR

Indexed keywords

MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; NEUROTRANSMITTER; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; BLOOD BRAIN BARRIER; BONE MARROW CELL; CENTRAL NERVOUS SYSTEM; GENE EXPRESSION; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HOMEOSTASIS; HUMAN; MACROPHAGE; MICROENVIRONMENT; MICROGLIA; NONHUMAN; OLIGODENDROGLIA; PHENOTYPE; PROTEIN EXPRESSION; REVIEW; STOCHASTIC MODEL;

EID: 84886752759     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2013.00065     Document Type: Review

References (186)

1. Aguzzi, A., Barres, B. A., and Bennett, M. L. (2013). Microglia: scapegoat, saboteur, or something else? Science 339,156-161.
2. Ajami, B., Bennett, J. L., Krieger, C., McNagny, K. M., and Rossi, F. M. (2011). Infiltrating monocytes trig-ger EAE progression, but do not contribute to the resident microglia pool. Nat. Neurosci. 14, 1142-1149.
3. Ajami, B., Bennett, J. L., Krieger, C., Tetzlaff, W., and Rossi, F. M. (2007). Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat. Neurosci. 10, 1538-1543.
4. Anderson, A. C., Anderson, D. E., Bre-goli, L., Hastings, W. D., Kassam, N., Lei, C., et al. (2007). Promo-tion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 318, 1141-1143.
5. Anderson, C. F., Gerber, J. S., and Mosser, D. M. (2002). Modulat-ing macrophage function with IgG immune complexes. J. Endotoxin Res. 8, 477-481.
6. Anderson, C. F., and Mosser, D. M. (2002). A novel phenotype for an activated macrophage: the type 2 acti-vatedmacrophage. J. Leukoc. Biol. 72, 101-106.
7. Balcaitis, S., Xie, Y., Weinstein, J. R., Andersen, H., Hanisch, U. K., Ran-som, B. R., et al. (2003). Expression of proteinase-activated receptors in mouse microglial cells. Neuroreport 14, 2373-2377.
8. Bechmann, I., Galea, I., and Perry, V. H. (2007). What is the blood-brain barrier (not)? Trends Immunol. 28, 5-11.
9. Biber, K., Neumann, H., Inoue, K., and Boddeke, H. W. (2007). Neu-ronal'On' and'Off' signals con-trol microglia. Trends Neurosci. 30, 596-602.
10. Bilbo, S. D., Biedenkapp, J. C., Der-Avakian, A., Watkins, L. R., Rudy, J. W., and Maier, S. F. (2005). Neonatal infection-induced mem-ory impairment after lipopolysaccha-ride in adulthood is prevented via caspase-1 inhibition. J. Neurosci. 25, 8000-8009.
11. Bilbo, S. D., and Schwarz, J. M. (2009). Early-life programming of later-life brain and behavior: a crit-ical role for the immune system. Front. Behav. Neurosci. 3:14. doi: 10.3389/neuro.08.014.2009
12. Biswas, S. K., and Mantovani, A. (2010). Macrophage plasticity and interac-tion with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 11, 889-896.
13. Bitsch, A., Schuchardt, J., Bunkowski, S., Kuhlmann, T., and Bruck, W. (2000). Acute axonal injury in multiple scle-rosis. Correlation with demyelination and inflammation. Brain 123(Pt 6), 1174-1183.
14. Block, M. L., Zecca, L., and Hong, J. S. (2007). Microglia-mediated neu-rotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8, 57-69.
15. Butovsky, O., Koronyo-Hamaoui, M., Kunis, G., Ophir, E., Landa, G., Cohen, H., et al. (2006a). Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc. Natl. Acad. Sci U.S.A. 103, 11784-11789.
16. Butovsky, O., Landa, G., Kunis, G., Ziv, Y., Avidan, H., Greenberg, N., et al. (2006b). Induction and block-age of oligodendrogenesis by differ-ently activated microglia in an animal model of multiple sclerosis. J. Clin. Invest. 116,905-915.
17. Butovsky, O., Ziv, Y., Schwartz, A., Landa, G., Talpalar, A. E., Pluchino, S., et al. (2006c). Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol. Cell. Neu-rosci. 31, 149-160.
18. Butovsky, O., Siddiqui, S., Gabriely, G., Lanser, A. J., Dake, B., Murugaiyan, G., et al. (2012). Modulating inflam-matory monocytes with a unique microRNA gene signature amelio-rates murine ALS. J. Clin. Invest. 122, 3063-3087.
19. Carson, M. J., Bilousova, T. V., Pun-tambekar, S. S., Melchior, B., Doose, J. M., and Ethell, I. M. (2007). A rose by any other name? The potential consequences of microglial heterogeneity during CNS health and disease. Neurotherapeutics 4, 571-579.
20. Carson, M. J., Reilly, C. R., Sut-cliffe, J. G., and Lo, D. (1998). Mature microglia resemble imma-ture antigen-presenting cells. Glia 22, 72-85.
21. Chang, N. C., Hung, S. I., Hwa, K. Y., Kato, I., Chen, J. E., Liu, C. H., et al. (2001). A macrophage protein, Ym1, transiently expressed during inflammation is a novel mammalian lectin. J. Biol. Chem. 276, 17497-17506.
22. Chen, G. Y., and Nunez, G. (2010). Ster-ile inflammation: sensing and react-ing to damage. Nat. Rev. Immunol. 10, 826-837.
23. Chen, S. K., Tvrdik, P., Peden, E., Cho, S., Wu, S., Spangrude, G., et al. (2010). Hematopoietic origin of pathological grooming in Hoxb8 mutant mice. Cell 141, 775-785.
24. Cho, H., Proll, S. C., Szretter, K. J., Katze, M. G., Gale, M. Jr., and Diamond, M. S. (2013). Differential innate immune response programs in neuronal subtypes determine suscep-tibility to infection in the brain by positive-stranded RNA viruses. Nat. Med. 19, 458-464.
25. Colton, C. A. (2009). Heterogene-ity of microglial activation in the innate immune response in the brain. J. Neuroimmune Pharmacol. 4, 399-418.
26. Colton, C. A., Mott, R. T., Sharpe, H., Xu, Q., Van Nostrand, W. E., and Vitek, M. P. (2006). Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J. Neuroinflammation 3, 27.
27. Cunningham, C. (2013). Microglia and neurodegeneration: the role of sys-temic inflammation. Glia 61, 71-90.
28. Daley, J. M., Brancato, S. K., Thomay, A. A., Reichner, J. S., and Albina, J. E. (2010). The phenotype of murine wound macrophages. J. Leukoc. Biol. 87, 59-67.
29. Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., et al. (2005). ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 8, 752-758.
30. David, S., andKroner, A. (2011). Reper-toire of microglial and macrophage responses after spinal cord injury. Nat. Rev. Neurosci. 12, 388-399.
31. Davoust, N., Vuaillat, C., Androdias, G., and Nataf, S. (2008). From bone marrow to microglia: barriers and avenues. Trends Immunol. 29, 227-234.
32. de Haas, A. H., Boddeke, H. W., and Biber, K. (2008). Region-specific expression of immunoregu-latory proteins on microglia in the healthy CNS. Glia 56, 888-894.
33. Derecki, N. C., Cronk, J. C., Lu, Z., Xu, E., Abbott, S. B., Guyenet, P. G., et al. (2012). Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature 484, 105-109.
34. Donnou, S., Fisson, S., Mahe, D., Montoni, A., and Couez, D. (2005). Identification of new CNS-resident macrophage subpopulation molecular markers for the dis-crimination with murine systemic macrophages. J. Neuroimmunol. 169, 39-49.
35. Draheim, H. J., Prinz, M., Weber, J. R., Weiser, T., Kettenmann, H., and Hanisch, U. K. (1999). Induction of potassium channels in mouse brain microglia: cells acquire responsive-ness to pneumococcal cell wall com-ponents during late development. Neuroscience 89,1379-1390.
36. Edwards, J. P., Zhang, X., Frauwirth, K. A., and Mosser, D. M. (2006). Bio-chemical and functional characteri-zation of three activated macrophage populations. J. Leukoc. Biol. 80, 1298-1307.
37. Ensinger, E. M., Boekhoff, T. M., Carlson, R., Beineke, A., Rohn, K., Tipold, A., et al. (2010). Regional topographical differences of canine microglial immunopheno-type and function in the healthy spinal cord. J. Neuroimmunol. 227, 144-152.
38. Fitzner, D., Schnaars, M., van Rossum, D., Krishnamoorthy, G., Dibaj, P., Bakhti, M., et al. (2011). Selec-tive transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. J. Cell Sci. 124, 447-458.
39. Foster, S. L., Hargreaves, D. C., and Medzhitov, R. (2007). Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447, 972-978.
40. Foster, S. L., and Medzhitov, R. (2009). Gene-specific control of the TLR-induced inflammatory response. Clin. Immunol. 130, 7-15.
41. Gautier, E. L., Shay, T., Miller, J., Greter, M., Jakubzick, C., Ivanov, S., et al. (2012). Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diver-sity of mouse tissue macrophages. Nat. Immunol. 13, 1118-1128.
42. Gerber, J. S., and Mosser, D. M. (2001). Reversing lipopolysaccharide toxic-ity by ligating the macrophage Fc gamma receptors. J. Immunol. 166, 6861-6868.
43. Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., et al. (2010). Fate mapping analy-sis reveals that adult microglia derive from primitive macrophages. Science 330,841-845.
44. Girard, S., Brough, D., Lopez-Castejon, G., Giles, J., Rothwell, N. J., and Allan, S. M. (2013). Microglia and macrophages differentially modulate cell death after brain injury caused by oxygen-glucose deprivation in organ-otypic brain slices. Glia 61, 813-824.
45. Gomez Perdiguero, E., Schulz, C., and Geissmann, F. (2013). Devel-opment and homeostasis of resi-dent" myeloid cells: the case of the microglia. Glia 61, 12-20.
46. Gordon, S., and Taylor, P. R. (2005). Monocyte and macrophage hetero-geneity. Nat. Rev. Immunol. 5, 953-964.
47. Graeber, M. B. (2010). Changing face of microglia. Science 330, 783-788.
48. Greter, M., and Merad, M. (2013). Regulation of microglia development and homeostasis. Glia 61, 121-127.
49. Hanisch, U. K. (2002). Microglia as a source and target of cytokines. Glia 40,140-155.
50. Hanisch, U. K. (2012). "Factors control-ling microglial activation", in Neu-roglia, eds H. Kettenmann and B. Ransom (New York: Oxford Univer-sity Press), 614-625.
51. Hanisch, U. K. (2013). Proteins in microglial activation -inputs and outputs by subsets. Curr. Protein Pept. Sci. 14, 3-15.
52. Hanisch, U. K., and Kettenmann, H. (2012). Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10,1387-1394.
53. Hanisch, U. K., van, R. D., Xie, Y., Gast, K., Misselwitz, R., Auriola, S., et al. (2004). The microglia-activating potential of thrombin: the protease is not involved in the induc-tion of proinflammatory cytokines and chemokines. J. Biol. Chem. 279, 51880-51887.
54. Hausler, K. G., Prinz, M., Nolte, C., Weber, J. R., Schumann, R. R., Ketten-mann, H., et al. (2002). Interferon-gamma differentially modulates the release of cytokines and chemokines in lipopolysaccharide-and pneumo-coccal cell wall-stimulated mouse microglia and macrophages. Eur. J. Neurosci. 16,2113-2122.
55. Haynes, S. E., Hollopeter, G., Yang, G., Kurpius, D., Dailey, M. E., Gan, W. B., et al. (2006). The P2Y12 receptor reg-ulates microglial activation by extra-cellular nucleotides. Nat. Neurosci. 9, 1512-1519.
56. He, B. P., Wang, J. J., Zhang, X., Wu, Y., Wang, M., Bay, B. H., et al. (2006). Differential reactions of microglia to brain metastasis of lung cancer. Mol. Med. 12, 161-170.
57. Heneka, M. T., Kummer, M. P., Stutz, (2010), Delekate, A., Schwartz, S., Vieira-Saecker, A., et al. (2013). NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 493, 674-678.
58. Heneka, M. T., Nadrigny, F., Regen, T., Martinez-Hernandez, A., Dumitrescu-Ozimek, L., Jardanhazi-Kurutz, D., et al. (2010). Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine. Proc. Natl. Acad. Sci. U.S.A. 107, 6058-6063.
59. Hristova, M., Cuthill, D., Zbarsky, V., costa-Saltos, A., Wallace, A., Blight, K., et al. (2010). Activation and deactivation of periventricular white matter phagocytes during postnatal mouse development. Glia 58, 11-28.
60. Hume, D.A. (2000). Probabilityin tran-scriptional regulation and its impli-cations for leukocyte differentiation and inducible gene expression. Blood 96, 2323-2328.
61. Ilschner, S., and Brandt, R. (1996). The transition of microglia to a rami-fied phenotype is associated with the formation of stable acetylated and detyrosinated microtubules. Glia 18, 129-140.
62. Iwama, S., Sugimura, Y., Suzuki, H., Suzuki, H., Murase, T., Ozaki, N., et al. (2011). Time-dependent changes in proinflammatory and neurotrophic responses of microglia and astrocytes in a rat model of osmotic demyelination syndrome. Glia 59, 452-462.
63. Kaul, D., Habbel, P., Derkow, K., Kruger, C., Franzoni, E., Wulczyn, F. G., et al. I. Expression of Toll-like recep-tors in the developing brain. PLoS ONE 7:e37767. doi: 10.1371/jour-nal.pone.0037767
64. Kawahara, K., Yoshida, A., Koga, K., Yokoo, S., Kuniyasu, A., Gotoh, T., et al. (2009). Marked induction of inducible nitric oxide synthase and tumor necrosis factor-alpha in rat CD40+ microglia by comparison to CD40-microglia. J. Neuroimmunol. 208, 70-79.
65. Kawai, T., and Akira, S. (2010). The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373-384.
66. Kettenmann, H., Hanisch, U. K., Noda, M., and Verkhratsky, A. (2011). Phys-iology of microglia. Physiol. Rev. 91, 461-553.
67. Kettenmann, H., Kirchhoff, F., and Verkhratsky, A. (2013). Microglia: new roles for the synaptic stripper. Neuron 77, 10-18.
68. Kierdorf, K., Erny, D., Goldmann, T., Sander, V., Schulz, C., Perdiguero, E. F., et al. (2013). Microglia emerge from erythromyeloid precursors via Pu.1-and Irf8-dependent pathways. Nat. Neurosci. 16, 273-280.
69. Kigerl, K. A., Gensel, J. C., Ankeny, D. P., Alexander, J. K., Donnelly, D. J., and Popovich, P. G. (2009). Identi-fication of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci. 29, 13435-13444.
70. Kim, W. G., Mohney, R. P., Wilson, (2011), Jeohn, G. H., Liu, B., and Hong, J. S. (2000). Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J. Neurosci. 20, 6309-6316.
71. Kitada, M., and Rowitch, D. H. (2006). Transcription factor co-expression patterns indicate hetero-geneity of oligodendroglial subpopu-lations in adult spinal cord. Glia 54, 35-46.
72. Kono, H., and Rock, K. L. (2008). How dying cells alert the immune system to danger. Nat. Rev. Immunol. 8, 279-289.
73. Kraft, A. D., McPherson, C. A., and Harry, G. J. (2009). Heterogene-ity of microglia and TNF signal-ing as determinants for neuronal death or survival. Neurotoxicology 30, 785-793.
74. Ladeby, R., Wirenfeldt, M., Dalmau, E., Gregersen, R., Garcia-Ovejero, D., Babcock, A., et al. (2005). Prolifer-ating resident microglia express the stem cell antigen CD34 in response to acute neural injury. Glia 50, 121-131.
75. Lai, A. Y., Dhami, K. S., Dibal, C. D., and Todd, K. G. (2011). Neonatal rat microglia derived from different brain regions have distinct activation responses. Neuron Glia Biol. 7, 5-16.
76. Landgraf, M., and Evers, J. F. (2005). Control of dendritic diversity. Curr. Opin. CellBiol. 17,690-696.
77. Lawrence, T., and Natoli, G. (2011). Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 11,750-761.
78. Lawson, L. J., Perry, V. H., Dri, P., and Gordon, S. (1990). Heterogene-ity in the distribution and mor-phology of microglia in the normal adult mouse brain. Neuroscience 39, 151-170.
79. Lehnardt, S., Schott, E., Trimbuch, T., Laubisch, D., Krueger, C., Wul-czyn, G., et al. (2008). A vicious cycle involving release of heat shock protein 60 from injured cells and acti-vation of toll-like receptor 4 medi-ates neurodegeneration in the CNS. J. Neurosci. 28, 2320-2331.
80. Liu, X., Zhan, Z., Li, D., Xu, L., Ma, E., Zhang, P., et al. (2011). Intracel-lular MHC class II molecules pro-mote TLR-triggered innate immune responses by maintaining activation of the kinase Btk. Nat. Immunol. 12, 416-424.
81. London, A., Benhar, I., Mattapallil, M. J., Mack, M., Caspi, R. R., and Schwartz, M. (2013). Functional macrophage heterogeneity in a mouse model of autoimmune central nervous system pathology. J. Immunol. 190, 3570-3578.
82. Lotze, M. T., Zeh, H. J., Rubartelli, A., Sparvero, L. J., Amoscato, A. A., Washburn, N. R., et al. (2007). The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immu-nity. Immunol. Rev. 220, 60-81.
83. Mantovani, A., Biswas, S. K., Galdiero, M. R., Sica, A., and Locati, M. (2013). Macrophage plasticity and polariza-tion in tissue repair and remodelling. J. Pathol. 229, 176-185.
84. Mantovani, A., Sica, A., Allavena, P., Garlanda, C., and Locati, M. (2009). Tumor-associated macrophages and the related myeloid-derived suppres-sor cells as a paradigm of the diver-sity of macrophage activation. Hum. Immunol. 70,325-330.
85. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., and Locati, M. (2004). The chemokine sys-tem in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677-686.
86. Maresz, K., Ponomarev, E. D., Barteneva, N., Tan, Y., Mann, M. K., and Dittel, B. N. (2008). IL-13 induces the expression of the alterna-tiveactivationmarkerYm1inasubset of testicular macrophages. J. Reprod. Immunol. 78,140-148.
87. Marshall, G. P., Demir, M., Steindler, D. A., and Laywell, E. D. (2008). Sub-ventricular zone microglia possess a unique capacity for massive in vitro expansion. Glia 56,1799-1808.
88. Martinez, F. O., Gordon, S., Locati, M., and Mantovani, A. (2006). Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177, 7303-7311.
89. Martinez, F. O., Helming, L., and Gor-don, S. (2009). Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 27, 451-483.
90. Martinez, F. O., Helming, L., Milde, R., Varin, A., Melgert, B. N., Draijer, et al. (2013). Genetic programs expressed in resting and IL-4 alter-natively activated mouse and human macrophages: similarities and differ-ences. Blood 121,e57-e69.
91. Matyash, V., and Kettenmann, H. (2012). Heterogeneity in astrocyte morphology and physiology. Brain Res. Rev. 63, 2-10.
92. Matzinger, P. (2007). Friendly and dan-gerous signals: is the tissue in control? Nat. Immunol. 8, 11-13.
93. McKay, S. M., Brooks, D. J., Hu, P., and McLachlan, E. M. (2007). Distinct types of microglial activation in white and grey matter of rat lumbosacral cord after mid-thoracic spinal tran-section. J. Neuropathol. Exp. Neurol. 66, 698-710.
94. Meeuwsen, S., Bsibsi, M., Persoon-Deen, C., Ravid, R., and van Noort, J. M. (2005). Cultured human adult microglia from differ-ent donors display stable cytokine, chemokine and growth factor gene profiles but respond differently to a pro-inflammatory stimu-lus. Neuroimmunomodulation 12, 235-245.
95. Mertsch, K., Hanisch, U. K., Ketten-mann, H., and Schnitzer, J. (2001). Characterization of microglial cells and their response to stimulation in an organotypic retinal culture system. J. Comp. Neurol. 431, 217-227.
96. Michelucci, A., Heurtaux, T., Grand-barbe, L., Morga, E., and Heuschling, P. (2009). Characterization of the microglial phenotype under spe-cific pro-inflammatory and anti-inflammatory conditions: effects of oligomeric and fibrillar amyloid-beta. J. Neuroimmunol. 210, 3-12.
97. Mikita, J., Dubourdieu-Cassagno, N., Deloire, M. S., Vekris, A., Biran, M., Raffard, G., et al. (2011). Altered M1/M2 activation patterns of mono-cytes in severe relapsing experimental rat model of multiple sclerosis. Ame-lioration of clinical status by M2 activated monocyte administration. Mult. Scler. 17, 2-15.
98. Mildner, A., Schlevogt, B., Kierdorf, K., Bottcher, C., Erny, D., Kummer, M. P., et al. (2011). Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer's disease. J. Neurosci. 31, 11159-11171.
99. Mildner, A., Schmidt, H., Nitsche, M., Merkler, D., Hanisch, U. K., Mack, M., et al. (2007). Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat. Neu-rosci. 10,1544-1553.
100. Miller, K. R., and Streit, W. J. (2007). The effects of aging, injury and dis-ease on microglial function: a case for cellular senescence. Neuron Glia Biol. 3, 245-253.
101. Mizutani, M., Pino, P. A., Saederup, N., Charo, I. F., Ransohoff, R. M., and Cardona, A. E. (2012). The fractalkine receptor but not CCR2 is present on microglia from embryonic development through-out adulthood. J. Immunol. 188, 29-36.
102. Monji, A., Kato, T., and Kanba, S. (2009). Cytokines and schizophrenia: microglia hypothesis of schizophre-nia. Psychiatry Clin. Neurosci. 63, 257-265.
103. Morrison, H. W., and Filosa, J. A. J. A quantitative spatiotempo-ral analysis of microglia morphology during ischemic stroke and reper-fusion. J. Neuroinflammation. 10:4. doi: 10.1186/1742-2094-10-4 [Epub ahead of print].
104. Mosser, D. M., and Edwards, J. P. G. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969.
105. Mouton, P. R., Long, J. M., Lei, D. L., Howard, V., Jucker, M., Calhoun, M. E., et al. (2002). Age and gen-der effects on microglia and astrocyte numbers in brains of mice. Brain Res. 956, 30-35.
106. Murray, P. J., and Wynn, T. A. (2011). Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11,723-737.
107. Naito, M., Umeda, S., Yamamoto, T., Moriyama, H., Umezu, H., Hasegawa, G., et al. (1996). Devel-opment, differentiation, and pheno-typic heterogeneity of murine tissue macrophages. J. Leukoc. Biol. 59, 133-138.
108. Neumann, H., and Daly, M. J. (2013). Variant TREM2 as risk factor for Alzheimer's disease. N. Engl. J. Med. 368, 182-184.
109. Neumann, H., Kotter, M. R., and Franklin, R. J. (2009). Debris clearance by microglia: an essen-tial link between degeneration and regeneration. Brain 132, 288-295.
110. Nimmerjahn, A., Kirchhoff, F., and Helmchen, F. (2005). Rest-ing microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314-1318.
111. Olah, M., Amor, S., Brouwer, N., Vinet, J., Eggen, B., Biber, K., et al. (2012). Identification of a microglia phe-notype supportive of remyelination. Glia60, 306-321.
112. Olah, M., Biber, K., Vinet, J., and Bod-deke, H. W. (2011). Microglia phe-notype diversity. CNSNeurol. Disord. Drug Targets 10, 108-118.
113. Pal, D., Dasgupta, S., Kundu, R., Maitra, S., Das, G., Mukhopadhyay, S., et al. (2012). Fetuin-A acts as an endoge-nous ligand of TLR4 to promote lipid-induced insulin resistance. Nat. Med. doi: 10.1038/nm.2851[Epub ahead of print].
114. Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., et al. (2011). Synaptic pruning by microglia is necessary for nor-mal brain development. Science 333, 1456-1458.
115. Perry, V. H., Crocker, P. R., and Gordon, S. (1992). The blood-brain barrier regulates the expression of a macrophage sialic acid-binding receptor on microglia. J. Cell Sci. 101(Pt 1), 201-207.
116. Perry, V. H., Cunningham, C., and Holmes, C. (2007). Systemic infections and inflammation affect chronic neurodegeneration. Nat. Rev. Immunol. 7, 161-167.
117. Piccinini, A. M., and Midwood, K. S. (2010). DAMPening inflamma-tion by modulating TLR signalling. MediatorsInflamm. 2010, 672395.
118. Piccio, L., Buonsanti, C., Cella, M., Tassi, I., Schmidt, R. E., Fenoglio, C., et al. (2008). Identification of solu-ble TREM-2 in the cerebrospinal fluid and its association with multiple scle-rosis and CNS inflammation. Brain 131,3081-3091.
119. Pocock, J. M., and Kettenmann, H. (2007). Neurotransmitter receptors on microglia. Trends Neurosci. 30, 527-535.
120. Pollard, J. W. (2009). Trophic macrophages in development and disease. Nat. Rev. Immunol. 9, 259-270.
121. Ponomarev, E. D., Maresz, K., Tan, Y., andDittel, B. N. (2007). CNS-derived interleukin-4 is essential for the regu-lation of autoimmune inflammation and induces a state of alternative acti-vation in microglial cells. J. Neurosci. 27,10714-10721.
122. Ponomarev, E. D., Shriver, L. P., and Dittel, B. N. (2006). CD40 expres-sion by microglial cells is required for their completion of a two-step acti-vation process during central nervous system autoimmune inflammation. J. Immunol. 176,1402-1410.
123. Ponomarev, E. D., Shriver, L. P., Maresz, K., and Dittel, B. N. (2005). Microglial cell activation and prolif-eration precedes the onset of CNS autoimmunity. J. Neurosci. Res. 81, 374-389.
124. Popovich, P. G., Guan, Z., Wei, P., Huitinga, I., van, R. N., and Stokes, B. T. (1999). Depletion of hematogenous macrophages pro-motes partial hindlimb recovery and neuroanatomical repair after experi-mental spinal cord injury. Exp. Neu-rol. 158,351-365.
125. Prinz, M., Priller, J., Sisodia, S. (2007) and Ransohoff, R. M. (2011). Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat. Neurosci. 13, 1227-1235.
126. Probst, A. V., Dunleavy, E., and Almouzni, G. (2009). Epigenetic inheritance during the cell cycle. Nat. Rev. Mol. Cell Biol. 10, 192-206.
127. Pukrop, T., Dehgani, F., Han-Ning, C., Lohaus, R., Byanga, K., Heermann, F. et al. (2010). Microglia promote colonization of brain tissue by breast cancer cells in a Wnt-dependent way. Glia 58,1477-1489.
128. Raes, G., Brys, L., Dahal, B. K., Brandt, J., Grooten, J., Brom-bacher, F., et al. (2005). Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflam-mation. J. Leukoc. Biol. 77, 321-327.
129. Raes, G., De, B. P., Noel, W., Beschin, A., Brombacher, F., and Hassanzadeh, G. F. (2002). Differential expression of FIZZ1 and Ym1 in alternatively ver-sus classically activated macrophages. J. Leukoc. Biol. 71,597-602.
130. Ransohoff, R. M., and Cardona, A. D. (2010). The myeloid cells of the central nervous system parenchyma. Nature 468, 253-262.
131. Ransohoff, R. M., and Engelhardt, B. (2012). The anatomical and cellu-lar basis of immune surveillance in the central nervous system. Nat. Rev. Immunol. 12,623-635.
132. Ransohoff, R. M., and Perry, V. G. (2009). Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 27, 119-145.
133. Ravasi, T., Wells, C., Forest, A., Underhill, D. M., Wainwright, B. J., Aderem, A., et al. (2002). Genera-tion of diversityin the innate immune system: macrophage heterogeneity arises from gene-autonomous tran-scriptional probability of individual inducible genes. J. Immunol. 168, 44-50.
134. Regen, T., van Rossum, D., Scheffel, J., Kastriti, M. E., Revelo, N. H., Prinz, M., et al. (2011). CD14 and TRIF govern distinct responsiveness and responses in mouse microglial TLR4 challenges by structural vari-ants of LPS. Brain Behav. Immun. 25, 957-970.
135. Rezaie, P., and Male, D. (1999). Coloni-sation of the developing human brain and spinal cord by microglia: a review. Microsc. Res. Tech. 45, 359-382.
136. Ribes, S., Adam, N., Ebert, S., Regen, T., Bunkowski, S., Hanisch, U. K., et al. (2011). The viral TLR3 agonist poly(I:C) stimulates phago-cytosis and intracellular killing of Escherichia coli by microglial cells. Neurosci. Lett. 482,17-20.
137. Ribes, S., Ebert, S., Czesnik, D., Regen, T., Zeug, A., Bukowski, S., et al. (2009). Toll-like receptor prestimulation increases phagocyto-sis of Escherichia coli DH5alpha and Escherichia coli K1 strains by murine microglial cells. Infect. Immun. 77, 557-564.
138. Ribes, S., Ebert, S., Regen, T., Agar-wal, A., Tauber, S. C., Czes-nik, D., et al. (2010a). Toll-like receptor stimulation enhances phagocytosis and intracellular killing of nonencapsulated and encapsu-lated Streptococcus pneumoniae by murine microglia. Infect. Immun. 78, 865-871.
139. Ribes, S., Ebert, S., Regen, T., Czes-nik, D., Scheffel, J., Zeug, A., et al. (2010b). Fibronectin stim-ulates Escherichia coli phagocyto-sis by microglial cells. Glia 58, 367-376.
140. Rivest, S. (2009). Regulation of innate immune responses in the brain. Nat. Rev. Immunol. 9, 429-439.
141. Rubartelli, A., and Lotze, M. T. (2007). Inside,outside, upside down: damage-associated molec-ular pattern molecules (DAMPs) and redox. Trends Immunol. 28, 429-436.
142. Saederup, N., Cardona, A. E., Croft, K., Mizutani, M., Cotleur, A. C., Tsou, C. L., et al. (2010). Selective chemokine receptor usage by cen-tral nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice. PLoS ONE 5:e13693. doi: 10.1371/journal.pone.0013693
143. Saijo, K., and Glass, C. K. (2011). Microglial cell origin and pheno-types in health and disease. Nat. Rev. Immunol. 11,775-787.
144. Satpathy, A. T., Wu, X., Albring, J. (2014) and Murphy, K. M. (2012). Re(de)fining the dendritic cell lin-eage. Nat. Immunol. 13, 1145-1154.
145. Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., et al. (2012). Microglia sculpt post-natal neural circuits in an activity and complement-dependent man-ner. Neuron 74, 691-705.
146. Scheffel, J., Regen, T., van Rossum, Seifert, S., Ribes, S., Nau, R., et al. (2012). Toll-like receptor acti-vation reveals developmental reor-ganization and unmasks responder subsets of microglia. Glia 60, 1930-1943.
147. Schlegelmilch, T., Henke, K., and Peri, F. K. Microglia in the developing brain: from immunity to behaviour. Curr. Opin. Neurobiol. 21, 5-10.
148. Schmid, C. D., Melchior, B., Masek, K., Puntambekar, S. S., Daniel-son, P. E., Lo, D. D., et al. H. Differential gene expres-sion in LPS/IFNgamma activated microglia and macrophages: in vitro versus in vivo. J. Neurochem. 109(Suppl. 1), 117-125.
149. Schmid, C. D., Sautkulis, L. N., Daniel-son, P. E., Cooper, J., Hasel, K. W., Hilbush, B. S., et al. (2002). Het-erogeneous expression of the trigger-ing receptor expressed on myeloid cells-2 on adult murine microglia. J. Neurochem. 83, 1309-1320.
150. Schulz, C., Gomez, P. E., Chorro, L., Szabo-Rogers, H., Cagnard, N., Kier-dorf, K., et al. (2012). A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336, 86-90.
151. Schwartz, M., Butovsky, O., Bruck, W., and Hanisch, U. K. (2006). Microglial phenotype: is the commit-ment reversible? Trends Neurosci. 29, 68-74.
152. Shen, A., Zhou, D., Shen, Q., Liu, H. O., Sun, L., Liu,Y., et al. (2009). The expression of tumor necrosis factor-alpha (TNF-alpha) by the intrathecal injection oflipopolysaccharide in the rat spinal cord. Neurochem. Res. 34, 333-341.
153. Sierra, A., Gottfried-Blackmore, A. (2008), McEwen, B. S., and Bulloch, K.G. Microglia derived from aging mice exhibit an altered inflammatory profile. Glia 55, 412-424.
154. Smedman, C., Ernemar, T., Gud-mundsdotter, L., Gille-Johnson, P., Somell, A., Nihlmark, K., et al. H. FluoroSpot analysis of TLR-activated monocytes reveals sev-eral distinct cytokine secreting sub-populations. Scand. J. Immunol. doi: 10.1111/j.1365-3083.2011.02641 [Epub ahead of print].
155. Snijder, B., Sacher, R., Ramo, P., Damm, M., Liberali, P., and Pelkmans, L. (2009). Population context deter-mines cell-to-cell variability in endo-cytosis and virus infection. Nature 461,520-523.
156. Sriram, K., Matheson, J. M., Benkovic, S. A., Miller, D. B., Luster, M. I., and O'Callaghan, J. P. (2006). Defi-ciency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-inducedneurotoxicity: role of TNF-alpha. FASEB J. 20, 670-682.
157. Starossom, S. C., Mascanfroni, I. E., Imitola, J., Cao, L., Rad-dassi, K., Hernandez, S. F., et al. I. Galectin-1 deactivates clas-sically activated microglia and pro-tects from inflammation-induced neurodegeneration. Immunity 37, 249-263.
158. Stewart, C. R., Stuart, L. M., Wilkinson, K., van Gils, J. M., Deng, J., Halle, A., et al. (2010). CD36 ligands pro-mote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol. 11, 155-161.
159. Stolp, H. B., Dziegielewska, K. M., Ek, C. J., Potter, A. M., and Saunders, N. R. (2005). Long-termchanges in blood-brain barrier permeability and white matter following prolonged systemic inflammation in early development in the rat. Eur. J. Neurosci. 22, 2805-2816.
160. Stolp, H. B., Ek, C. J., Johansson, P. A., Dziegielewska, K. M., Bethge, N., Wheaton, B. J., et al. (2009). Factors involved in inflammation-induced developmental white matter damage. Neurosci. Lett. 451, 232-236.
161. Streit, W. J., Miller, K. R., Lopes, K. O., and Njie, E. (2008). Microglial degeneration in the aging brain-bad news for neurons? Front. Biosci. 13, 3423-3438.
162. Suderman, M., McGowan, P. O., Sasaki, A., Huang, T. C., Hallett, M. T., Meaney, M. J., et al. (2012). Con-served epigenetic sensitivity to early life experience in the rat and human hippocampus. Proc. Natl. Acad. Sci U.S.A. 109(Suppl. 2), 17266-17272.
163. Sunderkotter, C., Nikolic, T., Dillon, M. J., van, R. N., Stehling, M., Drevets, D. A., et al. (2004). Subpop-ulations of mouse blood monocytes differ in maturation stage and inflam-matory response. J. Immunol. 172, 4410-4417.
164. Takeuchi, O., and Akira, S. (2010). Pattern recognition receptors and inflammation. Cell 140, 805-820.
165. Thored, P., Heldmann, U., Gomes-Leal, W., Gisler, R., Darsalia, V., Taneera, J., et al. (2009). Long-term accumu-lation of microglia with proneuro-genic phenotype concomitant with persistent neurogenesis in adult sub-ventricular zone after stroke. Glia 57, 835-849.
166. Tierney, J. B., Kharkrang, M., and La Flamme, A. C. (2009). Type II-activated macrophages suppress the development of experimen-tal autoimmune encephalomyelitis. Immunol. CellBiol. 87,235-240.
167. Town, T., Nikolic, V., and Tan, J. (2013). The microglial activation continuum: from innate to adap-tive responses. J. Neuroinflammation. 2, 24.
168. Tremblay, M. E., Stevens, B., Sierra, A., Wake, H., Bessis, A., and Nimmer-jahn,A. (2011). The role of microglia in the healthy brain. J. Neurosci. 31, 16064-16069.
169. Treves, A. J. (1984). The origin of monocyte-macrophage hetero-geneity: possible alternatives. Med. Hypotheses 14, 335-346.
170. Van den Bossche, J., Laoui, D., Morias, Y., Movahedi, K., Raes, G., De, B. P., et al. (2012). Claudin-1, claudin-2 and claudin-11 genes differen-tially associate with distinct types of anti-inflammatory macrophages in vitro and with parasite-and tumour-elicited macrophages in vivo. Scand. J. Immunol. 75, 588-598.
171. van Rossum, D., and Hanisch, U. K. (2004). Microglia. Metab. Brain Dis. 19,393-411.
172. van Rossum, D., Hilbert, S., Strassen-burg, S., Hanisch, U. K., and Bruck, W. (2008). Myelin-phagocytosing macrophages in isolated sciatic and optic nerves reveal a unique reactive phenotype. Glia 56, 271-283.
173. van Weering, H. R., Boddeke, H. W., Vinet, J., Brouwer, N., de Haas, A. H., van, R. N., et al. I. CXCL10/CXCR3 signaling in glia cells differentially affects NMDA-induced cell death in CA and DG neurons of the mouse hippocampus. Hippocampus 21, 220-232.
174. Varvel, N. H., Grathwohl, S. A., Bau-mann, F., Liebig, C., Bosch, A., Brawek, B., et al. (2012). Microglial repopulation model reveals a robust homeostatic process for replacing CNS myeloid cells. Proc. Natl. Acad. Sci U.S.A. 109, 18150-18155.
175. Venkatesan, C., Chrzaszcz, M., Choi, N., and Wainwright, M. S. (2010). Chronic upregulation of acti-vated microglia immunoreactive for galectin-3/Mac-2 and nerve growth factor following diffuse axonal injury. J. Neuroinflammation 7, 32.
176. Wake, H., Moorhouse, A. J., Jinno, S., Kohsaka, S., and Nabekura, J. (2009). Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J. Neurosci. 29, 3974-3980.
177. Walton, N. M., Sutter, B. M., Lay-well, E. D., Levkoff, L. H., Kearns, S. M., Marshall, G. P., et al. (2015). Microglia instruct subven-tricular zone neurogenesis. Glia 54, 815-825.
178. Weber, M. S., Prod'Homme, T., Youssef, S., Dunn, S. E., Rundle, C. D., Lee, L., et al. (2007). Type II monocytes mod-ulate T cell-mediated central nervous system autoimmune disease. Nat. Med. 13, 935-943.
179. Wei, G., Wei, L., Zhu, J., Zang, C., Hu-Li, J., Yao, Z., et al. (2009). Global map-ping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differ-entiating CD4+ T cells. Immunity 30, 155-167.
180. Wilms, H., Wollmer, M. A., and Sievers, J. (1999). In vitro-staining specificity of the antibody 5-D-4 for microglia but not for mono-cytes and macrophages indicates that microglia are a unique subgroup of the myelomonocytic lineage. J. Neu-roimmunol. 98, 89-95.
181. Wong, S. C., Puaux, A. L., Chittezhath, M., Shalova, I., Kajiji, T. S., Wang, X., et al. (2010). Macrophage polar-ization to a unique phenotype driven by B cells. Eur. J. Immunol. 40, 2296-2307.
182. Yona, S., and Jung, S. (2010). Mono-cytes: subsets, origins, fates and functions. Curr. Opin. Hematol. 17, 53-59.
183. Yona, S., Kim, K. W., Wolf, Y., Mild-ner, A., Varol, D., Breker, M., et al. (2015). Fate mapping reveals ori-gins and dynamics of monocytes and tissue macrophages under homeosta-sis. Immunity 38, 79-91.
184. Zerrate, M. C., Pletnikov, M., Con-nors, S. L., Vargas, D. L., Seidler, F. J., Zimmerman, A. W., et al. (2007). Neuroinflammation and behavioral abnormalities after neonatal terbu-taline treatment in rats: implications for autism. J. Pharmacol. Exp. Ther. 322, 16-22.
185. Zhang, X., and Mosser, D. M. (2008). Macrophage activation by endoge-nous danger signals. J. Pathol. 214, 161-178.
186. Zhou, X., Spittau, B., and Krieglstein, K. (2012). TGFbeta signalling plays an important role in IL-4-induced alternative activation of microglia. J. Neuroinflammation 9:210. doi: 10.1186/1742-2094-9-210 [Epub ahead of print].